Free Trial

Brooklyn ImmunoTherapeutics (BTX) Stock Trends and Sentiment

$1.83
-0.02 (-1.08%)
(As of 05/30/2024 ET)

MarketBeat Searches Over Time

Recieve Brooklyn ImmunoTherapeutics News and Ratings via Email

Sign-up to receive the latest news and ratings for BTX and its competitors with MarketBeat's FREE daily newsletter.

Related Companies and Tools

This page (NYSE:BTX) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners